AZTA vs BIO · rev $159.2M vs rev $651.0M
Azenta Inc (AZTA) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Azenta Inc (AZTA) is a medical instruments & supplies company listed on US.
BIO (BIO) common stock.
Latest reported AZTA revenue for 2025-09-30 was $159.2M. Net income was $50.9M. Revenue was up 10.7% from 2025-06-30 to 2025-09-30. AZTA currently screens at market cap $1.05B.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
AZTA currently screens at market cap $1.05B. BIO currently screens at market cap $0.
Not investment advice. Open the AZTA and BIO stock pages for the full models.
Not investment advice.